HUP0003116A2 - Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok - Google Patents
Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidokInfo
- Publication number
- HUP0003116A2 HUP0003116A2 HU0003116A HUP0003116A HUP0003116A2 HU P0003116 A2 HUP0003116 A2 HU P0003116A2 HU 0003116 A HU0003116 A HU 0003116A HU P0003116 A HUP0003116 A HU P0003116A HU P0003116 A2 HUP0003116 A2 HU P0003116A2
- Authority
- HU
- Hungary
- Prior art keywords
- amyloid peptide
- proteins
- betha
- same
- subject
- Prior art date
Links
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 102000023856 peptide binding proteins Human genes 0.000 title 1
- 108091008399 peptide binding proteins Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Atalálmány tárgyát b-amiloidpeptidhez kötődő új polinukleotidok és azáltaluk kódolt fehérjék, a fehérjéket vagy részeiket kódoló fúziósfehérjék és a hozzájuk kötődő antitestek képezik, továbbá eljárásokezek előállítására. Atalálmány tárgyát képezik továbbá a találmányszerinti polinukleotidokkal transzformált gazdasejtek és az azokattartalmazó transzgenikus állatok. Atalálmány tárgyát képezik továbbáeljárások a fehérjék és a nukleotidok terápiás, diagnosztikai éskutatási célokra való alkalmazására. A találmány szerinti megoldásAlzheimer-kór kezelésében, diagnózisában, továbbá az ezzel a kórralkapcsolatos kutatások területén alkalmazható. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6458397P | 1997-04-16 | 1997-04-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0003116A2 true HUP0003116A2 (hu) | 2001-01-29 |
HUP0003116A3 HUP0003116A3 (en) | 2003-03-28 |
Family
ID=22056941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0003116A HUP0003116A3 (en) | 1997-04-16 | 1998-04-14 | Betha-amyloid peptide-binding proteins and polynucleotides encoding the same |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0975753A2 (hu) |
JP (3) | JP2001523093A (hu) |
KR (1) | KR20010006393A (hu) |
CN (2) | CN1690203A (hu) |
AU (1) | AU740445B2 (hu) |
BR (1) | BR9808562A (hu) |
CA (1) | CA2286484A1 (hu) |
EA (1) | EA004256B1 (hu) |
EE (1) | EE9900482A (hu) |
GE (1) | GEP20043386B (hu) |
HU (1) | HUP0003116A3 (hu) |
ID (1) | ID24914A (hu) |
IL (3) | IL132236A0 (hu) |
NO (1) | NO995062L (hu) |
NZ (1) | NZ500216A (hu) |
SK (1) | SK143299A3 (hu) |
UA (1) | UA72875C2 (hu) |
WO (1) | WO1998046636A2 (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005295B1 (en) | 1997-04-16 | 2006-02-28 | Wyeth | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
US6787319B2 (en) * | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
AU769307B2 (en) * | 1998-10-13 | 2004-01-22 | Wyeth | G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
US6455082B1 (en) * | 1999-04-26 | 2002-09-24 | Nestec S.A. | Shelf-stable calcium fortified milk and dairy products |
WO2001029225A1 (en) * | 1999-10-21 | 2001-04-26 | Panorama Research, Inc. | A general method for optimizing the expression of heterologous proteins |
US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
US7807171B2 (en) | 2003-07-25 | 2010-10-05 | Ac Immune Sa | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
US9289488B2 (en) | 2010-08-12 | 2016-03-22 | Ac Immune Sa | Vaccine engineering |
CA2813833C (en) | 2010-10-26 | 2020-09-22 | Ac Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
CN102060912B (zh) * | 2010-11-22 | 2012-11-14 | 清华大学 | 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用 |
CN111320678B (zh) * | 2020-03-09 | 2023-06-09 | 安亭生物有限责任公司 | 抗菌肽突变体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE169673T1 (de) * | 1986-11-17 | 1998-08-15 | Scios Inc | Rekombiniertes alzheimer amyloid-protein |
IL115743A0 (en) * | 1994-10-28 | 1996-01-19 | American Nat Red Cross | A mammal with cells containing a transgene and its production |
US5786180A (en) * | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
-
1998
- 1998-04-14 UA UA99116193A patent/UA72875C2/uk unknown
- 1998-04-14 CN CNA200510052975XA patent/CN1690203A/zh active Pending
- 1998-04-14 GE GE3744A patent/GEP20043386B/en unknown
- 1998-04-14 IL IL13223698A patent/IL132236A0/xx active IP Right Grant
- 1998-04-14 EA EA199900941A patent/EA004256B1/ru not_active IP Right Cessation
- 1998-04-14 AU AU71156/98A patent/AU740445B2/en not_active Ceased
- 1998-04-14 SK SK1432-99A patent/SK143299A3/sk unknown
- 1998-04-14 CA CA002286484A patent/CA2286484A1/en not_active Abandoned
- 1998-04-14 WO PCT/US1998/007462 patent/WO1998046636A2/en active Application Filing
- 1998-04-14 KR KR1019997009480A patent/KR20010006393A/ko not_active Application Discontinuation
- 1998-04-14 JP JP54419698A patent/JP2001523093A/ja active Pending
- 1998-04-14 BR BR9808562-0A patent/BR9808562A/pt not_active Application Discontinuation
- 1998-04-14 EP EP98918186A patent/EP0975753A2/en not_active Withdrawn
- 1998-04-14 EE EEP199900482A patent/EE9900482A/xx unknown
- 1998-04-14 NZ NZ500216A patent/NZ500216A/xx unknown
- 1998-04-14 HU HU0003116A patent/HUP0003116A3/hu unknown
- 1998-04-14 CN CNB988043173A patent/CN1196785C/zh not_active Expired - Fee Related
- 1998-04-14 ID IDW991187D patent/ID24914A/id unknown
-
1999
- 1999-10-06 IL IL132236A patent/IL132236A/en not_active IP Right Cessation
- 1999-10-15 NO NO995062A patent/NO995062L/no not_active Application Discontinuation
-
2006
- 2006-11-05 IL IL179047A patent/IL179047A0/en unknown
-
2007
- 2007-12-28 JP JP2007339660A patent/JP2008104465A/ja active Pending
-
2008
- 2008-06-18 JP JP2008159606A patent/JP2008253275A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
GEP20043386B (en) | 2004-02-10 |
EE9900482A (hu) | 2000-06-15 |
IL179047A0 (en) | 2007-03-08 |
IL132236A (en) | 2007-03-08 |
KR20010006393A (ko) | 2001-01-26 |
CA2286484A1 (en) | 1998-10-22 |
HUP0003116A3 (en) | 2003-03-28 |
AU740445B2 (en) | 2001-11-01 |
AU7115698A (en) | 1998-11-11 |
BR9808562A (pt) | 2000-05-23 |
JP2008104465A (ja) | 2008-05-08 |
IL132236A0 (en) | 2001-03-19 |
EA199900941A1 (ru) | 2000-06-26 |
WO1998046636A2 (en) | 1998-10-22 |
ID24914A (id) | 2000-08-31 |
EP0975753A2 (en) | 2000-02-02 |
SK143299A3 (en) | 2000-09-12 |
CN1196785C (zh) | 2005-04-13 |
CN1690203A (zh) | 2005-11-02 |
JP2008253275A (ja) | 2008-10-23 |
EA004256B1 (ru) | 2004-02-26 |
NO995062L (no) | 1999-12-14 |
NO995062D0 (no) | 1999-10-15 |
CN1268973A (zh) | 2000-10-04 |
UA72875C2 (uk) | 2005-05-16 |
JP2001523093A (ja) | 2001-11-20 |
WO1998046636A3 (en) | 1999-01-28 |
NZ500216A (en) | 2001-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2278463T3 (es) | Metodo para reducir la inmunogenicidad de proteinas. | |
BRPI0511118A (pt) | polipeptìdeos de haemophilus influenzae não transcritos | |
ATE354638T1 (de) | Menschlicher gewebsinhibitor von metalloproteinase-4 | |
DE69431834D1 (de) | Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung | |
DE69922261D1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
DE60140218D1 (de) | Expressionsvektor für tierische zellen | |
DK0751992T3 (da) | Karendotelvækstfaktor 2 | |
DK0910647T3 (da) | Human DNase i hyperaktive varianter | |
DE69534402D1 (de) | Apoptose-proteasen 3 und 4, ähnlich dem umwandlungsenzym für interleukin-1beta | |
HUP0003116A2 (hu) | Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok | |
DK43890D0 (da) | Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse | |
CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
NZ531570A (en) | DNA sequences for human angiogenesis genes | |
HUP0102479A2 (hu) | Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek | |
SG121733A1 (en) | Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
EP1270588A4 (en) | NEW COLLAGEN-LIKE PROTEIN CLAC, ITS PRECURSORS AND GENES CODING THEREFOR | |
BR0007816A (pt) | Fator de estimulação óssea | |
ATE278011T1 (de) | Human dnase ii | |
WO2002088378A3 (en) | 66784, a novel human potassium channel and uses therefor | |
DE50015355D1 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
ATE109509T1 (de) | Anticoagulatorisches protein pp4-x, seine herstellung und verwendung. | |
DE60120507D1 (de) | Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 | |
ATE460673T1 (de) | Screeningverfahren zum identifizieren protektiver substanzen für die behandlung neurodegenerativer und/oder ischämischer erkrankungen | |
HUP0203689A2 (hu) | Interleukin-1 receptor antagonistaszerű molekulák és ezek használata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees | ||
HA9A | Change in inventorship |